Julie Bowen

TheÂ  National Diabetes Statistics Report, 2017 from the CDC provides data on the incidence and prevalence of diabetes, prediabetes, risk factors for complications, and acute and long-term complications-as well as deaths and costs.See if you can determine whether the 10 True or False statements (above) based on these data are facts or fiction. Good luck.

1. Centers for Disease Control and Prevention. 

 National Diabetes Statistics Report, 2017. 

 Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2017.2. Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. 

 Incidence trends of type 1 and type 2 diabetes among youths, 2002â2012. 

 N Engl J Med. 2017;376:1419-1429.3. Centers for Disease Control and Prevention. About Underlying Cause of Death 1999â2015. 

 Updated December 2016. Accessed October 24, 2017.4. American Diabetes Association. 

 Economic costs of diabetes in the U.S. in 2012. 

Slideshows

Can you sort out diabetes facts from fiction? The latest diabetes statistics from the CDC may surprise you. 

True or False: Diabetes Stats 2017

Click through the slides above for our monthly at-a-glance reviews of recent studies in T2DM. Among our October topics:
• CV and renal outcomes with SGLT2 inhibitors
• Insulins go head to head
• Add-on options for metforminSee the slide legends for links to article summaries.

At-a-glance: SGLT2 inhibitors, GLP-1 agonists, insulin vs insulin, and more-a look at what’s new, what’s next.

T2D Study Guide, October: SGLT2 Inhibitors, GLP-1 Agonists, CV Outcomes  

Click through the slides above for our monthly at-a-glance reviews of recent studies in endocrinology. Among our September topics:
• Risk of atrial fibrillation in patients with T1DM
• Novel predictors of postmenopausal fracture
• Clinical implications of weight variability

At-a-Glance: Studies you may find of interest look at AFib in T1DM, new fracture risk data, obesity outcomes, and more.

Interesting Endo: AFib, Bone Health, and Obesity

Are you up-to-date on the preferred antidiabetes agents for bone health? The optimal duration of bisphosphonate therapy? The effects of omega-3 supplements on diabetic neuropathy? Take this quick quiz and find out.

Note: If you would like more information on any of the questions, a link to the original article, “Interesting Endo: Obesity and Osteoporosis,” is provided on the last page of the quiz.

Click below for answer and next question. 

The correct answer is C. Thiazolidinediones

Click below for answer and next question.

The correct answer is B. Caregiver body mass index

The correct answer is A. Waist-to-height ratio

Click below for answer and additional information. 

For more information on all questions and answers, please visit 

“Interesting Endo: Obesity and Osteoporosis.”

Articles

What's new in research on bisphosphonates, body-fat measurement, prebiotics, and insulin dosing? Find out with our quiz.

Author | Julie Bowen

Articles

True or False: Diabetes Stats 2017

T2D Study Guide, October: SGLT2 Inhibitors, GLP-1 Agonists, CV Outcomes

Interesting Endo: AFib, Bone Health, and Obesity

Endocrinology News Quiz: Obesity and Osteoporosis